pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
relacorilant
Lifyorli (relacorilant)
Epithelial Ovarian Cancer
$CORTCORCEPT THERAPEUTICS INC
0 catalysts
Phase 2
relatlimab
Metastatic Hepatocellular Carcinoma (HCC)
Lymphocyte activation gene 3 protein
Bristol-Myers Squibb Co
0 catalysts
Phase 2
remetinostat
Cutaneous T-Cell Lymphoma
Biossil Inc
0 catalysts
← prev
page 56 of 62
next →
131
Pain89
Neurology1
Phase 1
remzistotug
Breast Cancer
$GSKGSK plc
0 catalysts
Phase 2
rencofilstat
Hepatocellular Carcinoma
$HEPAHepion Pharmaceuticals, Inc.
0 catalysts
Marketed
repotrectinib
Augtyro (repotrectinib)
Non-Small Cell Lung Cancer
NT-3 growth factor receptorBDNF/NT-3 growth factors receptor
Bristol-Myers Squibb Co
0 catalysts
Phase 2
resiquimod
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Toll-like receptor 7Toll-like receptor 8
SURGE Therapeutics Inc
0 catalysts
Phase 2
resiquimod sulfate
Squamous Non-Small Cell Lung Cancer
$EIKNEikon Therapeutics, Inc.
0 catalysts
Phase 2
rezatapopt
Bile Duct Cancer (Cholangiocarcinoma)
$PMVPPMV Pharmaceuticals, Inc.
0 catalysts
Phase 2
rhenium (186Re) obisbemeda
Reyobiq (rhenium (186Re) obisbemeda)
Malignant Glioma
$PSTVPLUS THERAPEUTICS, INC.
0 catalysts
Marketed
ribociclib succinate
Kisqali (ribociclib succinate)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Cyclin-dependent kinase 4Cyclin-dependent kinase 6
$NVSNOVARTIS AG
0 catalysts
Phase 2
rigosertib sodium
Non-Small Cell Lung Cancer
$TRAWTraws Pharma, Inc.
0 catalysts
Phase 1
rilogrotug
Cancer Anorexia-Cachexia Syndrome
AVEO Pharmaceuticals Inc
0 catalysts
Phase 3
rinatabart sesutecan
Epithelial Ovarian Cancer
Genmab AS
0 catalysts
Phase 2
rintatolimod
Ampligen (rintatolimod)
Epithelial Ovarian Cancer
Toll-like receptor 3
$AIMAIM ImmunoTech Inc.
0 catalysts
Phase 1
rinzimetostat
rinzimetostat [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$ORICOric Pharmaceuticals, Inc.
0 catalysts
Marketed
ripretinib
Qinlock (ripretinib)
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals Inc
0 catalysts
Preclinical
ritanserin
Glioblastoma Multiforme (GBM)
University of Virginia
0 catalysts
Marketed
rituximab
Rituxan (rituximab)
B-Cell Leukemia
Genentech Inc
0 catalysts
pre_registration
rituximab biosimilar
Riabni (rituximab-arrx)
Unspecified Cancer
B-lymphocyte antigen CD20
Dr. Reddy's Laboratories Ltd
0 catalysts
Phase 2
roginolisib
roginolisib [INN]
Metastatic Uveal Melanoma
iOnctura SA
0 catalysts
Phase 2
rogocekib
rogocekib [INN]
Chronic Myelomonocytic Leukemia (CMML)
Chordia Therapeutics Inc
0 catalysts
Marketed
romidepsin
Romidepsin (romidepsin)
Cutaneous T-Cell Lymphoma
Fresenius Kabi USA LLC
0 catalysts
Phase 2
rondecabtagene autoleucel
rondecabtagene autoleucel [INN]
Diffuse Large B-Cell Lymphoma
$LYELLyell Immunopharma, Inc.
0 catalysts
pre_registration
ropeginterferon alfa-2b LA
Besremi (ropeginterferon alfa-2b [INN])
Essential Thrombocythemia
PharmaEssentia Corp
0 catalysts
Phase 2
rose bengal sodium
rose bengal sodium [INN]
Metastatic Melanoma
$PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
0 catalysts
Phase 2
rosopatamab tetraxetan
rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Convergent Therapeutics Inc
0 catalysts
Phase 3
rostaporfin
Metastatic Breast Cancer
TuHURA Biosciences Inc
0 catalysts
Phase 2
roxadustat
Myelodysplastic Syndrome (Preleukemia)
Hypoxia-inducible factor prolyl hydroxylase
$KYNBKYNTRA BIO, INC.
0 catalysts
pre_registration
rusfertide acetate
Polycythemia Vera
$PTGXProtagonist Therapeutics, Inc
0 catalysts